Quick Answer
iSpecimen Inc. reported Diluted EPS of $17.58 per share (loss) for fiscal year 2024.
iSpecimen Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2024 | -$17.58 | +28.4% |
| 2023 | -$24.55 | -2016.4% |
| 2022 | -$1.16 | +44.5% |
| 2021 | -$2.09 | +57.9% |
| 2020 | -$4.97 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.48 | +77.1% | -14.3% |
| June 30, 2025 | -$0.42 | +88.7% | +40.8% |
| March 31, 2025 | -$0.71 | +88.8% | +66.2% |
| September 30, 2024 | -$2.10 | +54.9% | +43.5% |
| June 30, 2024 | -$3.72 | -853.8% | +41.5% |
| March 31, 2024 | -$6.36 | -2255.6% | -36.5% |
| September 30, 2023 | -$4.66 | -1231.4% | -1094.9% |
| June 30, 2023 | -$0.39 | -30.0% | -44.4% |
- iSpecimen Inc. showed an increase of +28.4% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2024 period, iSpecimen Inc.’s diluted eps has declined by 253.7% (from $4.97 per share (loss) to $17.58 per share (loss)).
- The most recent figure is from iSpecimen Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 14, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: